Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Assessing Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain Patients With Renal Insufficiency

View source ↗

Summary

This update outlines a planned clinical trial evaluating hydromorphone sustained-release tablets for cancer pain in elderly patients with renal insufficiency; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydromorphone sustained-release tablets (hydromorphone)

Snippet

Sponsor: Taian Cancer Hospital | Conditions: Cancer Pain, Renal Insufficiency Chronic | Status: NOT_YET_RECRUITING